Following the collapse of the Soviet Union, Ukraine inherited a centrally controlled health system that funded almost half of health expenditures, as of 2014. Out-of-pocket payments accounted for more than 46% of the rest, and a third of that was for medicines, which are expensive. Affordable medicines were out of reach for many people.
Building upon the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, the SAFE and Affordable Medicines for Ukrainians (SAFEMed) Activity (2017-2022) aims to bolster pharmaceutical governance and financing, contribute to a longer-term plan for pharmaceutical financing, and strengthen rational pharmaceutical management and the pharmaceutical supply chain, ultimately leading to better availability and use of essential medicines in Ukraine.
- Supported the Ministry of Health in adopting e-TB Manager as the national TB registry in 2015 to improve the management of pharmaceutical information and curb the spread of TB. The time needed to prepare facility-, regional-, and national-level TB reports decreased from several days to one or two hours, and compliance with national quarterly reporting guidelines increased from 77% to 98%. The web-based platform has been rolled out in every region of Ukraine, allowing Ukraine’s National TB Program to more accurately assess and monitor epidemiological trends, identify potential issues, and plan regional interventions.
- Supported an update of the essential medicines list—medicines eligible for public procurement—and its expert committee.
- Advised on legislation for fair medicine distribution, making procurement more efficient and less vulnerable to conflicts of interest.
- Strengthened the National Health Technology Assessment Agency, which assists the Ministry of Health in reviewing the country's publicly financed health benefits package, making more effective use of these funds.
- In 2018, supported the launch of Ukraine’s first medical Central Procurement Agency.
- Developed the programmatic, financial, and operational capacity of the Ukrainian Center for Socially Dangerous Disease Control as a Global Fund Principal Recipient and a key player in the public health system.
- Provided technical support to launch The Affordable Medicines state reimbursement program. As of April 2017, the program is making 21 essential medicines for cardiovascular disease, type 2 diabetes, and asthma more affordable and accessible to Ukrainians. The program will expand with the goal of covering the entire essential medicines list for outpatient treatment to enhance access to TB medicines, antiretrovirals, and other essential medicines for treating infectious diseases.
- 6.8 million e-prescriptions issued by family doctors since April 2019 throughout Ukraine; 5.7 million of those (84%), amounting to more than 400 million Ukrainian Hryvna, have been filled by 7,638 participating pharmacies.
- Contributed to health care reform by providing technical assistance for policy development, capacity building, and governance improvements. MSH supported the development of the national medicines policy, a concept paper for health care financing reform, and a concept note on reforming public procurement of medicines.
- With funding from the World Bank, helped Ukraine identify and address barriers to managed entry agreements with private manufacturers, thereby reducing financial barriers for purchasing medicines for non-communicable diseases.
|Project Name||Health Systems||Health Areas||Date|
|Safe, Affordable, and Effective Medicines for Ukrainians||Financing Health Services, Leadership, Management & Governance, Pharmaceutical Management||HIV & AIDS, Tuberculosis||2017 - 2022|
|Building Capacity for National Public Health Institutes||Leadership, Management & Governance, Global Health Security||2020 - 2025|
Leadership, Management and Governance Project
|Leadership, Management & Governance||Women's, Children's, and Adolescents' Health, HIV & AIDS, Tuberculosis||2012 - 2017|
Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program
|Pharmaceutical Management, Financing Health Services, Global Health Security||Malaria, Tuberculosis, HIV & AIDS, Women's, Children's, and Adolescents' Health||2011 - 2018|